This federal contract award, identified as SPE2DE20D0027|SPE2DE21F0014, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The award, valued at $25,025,112.52, is for the delivery of BinaxNOW COVID-19 antigen test cards to support the government's response to the Coronavirus (COVID-19) pandemic.
The contract is a firm fixed-price delivery order, without any set-aside designation, and is part of a larger Indefinite Delivery Vehicle (IDV) contract held by Abbott Rapid DX North America LLC. This vendor has secured several significant IDVs with the Department of Veterans Affairs (VA) to provide COVID-19 testing supplies and services, as well as other medical diagnostic equipment and reagents, to support the VA's public health initiatives and medical readiness programs. As a global healthcare company, Abbott Laboratories has a strong presence in supplying a diverse range of medical products, including diagnostic systems, medical devices, and pharmaceuticals, to various federal agencies.